サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：カペシタビンの世界市場：症状別、合成タイプ別、予測（2023年～2032年）
市場調査レポート
商品コード
1394978

カペシタビンの世界市場：症状別、合成タイプ別、予測（2023年～2032年）

Capecitabine Market Size - By Indication (Breast, Colorectal, Gastric, Pancreatic), By Synthesis Type (Chemical Based API, Biological API, Highly Potent API, Mode), Global Forecast 2023- 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 162 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
カペシタビンの世界市場：症状別、合成タイプ別、予測（2023年～2032年）
出版日: 2023年10月03日
発行: Global Market Insights Inc.
ページ情報: 英文 162 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のカペシタビンの市場規模は、2023年～2032年にCAGR4.9％で拡大すると予測されます。

乳がんや大腸がんを含むさまざまながんの罹患率の上昇が、効果的な化学療法薬に対する需要を煽っています。

がん治療プロトコルの急速な進歩が、経口化学療法の選択肢としてカペシタビンの採用を促進しています。さらに、研究開発活動の継続と製品承認数の増加が、カペシタビンの有効性と安全性の向上につながっています。例えば、2022年12月、米国FDAはProject Renewalの一環としてカペシタビン錠剤の添付文書更新を承認しました。オンコロジー・センター・オブ・エクセレンスが主導するこのイニシアチブは、特定の旧型のがん治療薬について、臨床的に有意義であると同時に科学的にも最新の情報を確保することを目的としています。

世界の高齢化社会の進展とがんに対する意識の高まりは、増大するがんの負担に対処する上でカペシタビンの重要性を強調しています。経口投与の利便性、患者のコンプライアンス強化のための通院回数の減少も市場成長を促進する要因です。

カペシタビン産業は、症状、合成タイプ、モード、地域に分類されます。

症状別では、大腸がんセグメントの業界価値は2032年までCAGR5.3％で上昇すると推定されます。大腸がんの有病率の増加とがん治療プロトコルの急速な進歩が、化学療法の選択肢としてのカペシタビンの有効性を促進しています。大腸がんの治療におけるカペシタビンの有効性は、したがって、セグメントの成長に拍車をかけると思われます。

生物学的API合成タイプセグメントからのカペシタビン市場シェアは、2023年～2032年にCAGR4.9％で増加すると予測されます。この成長は、バイオテクノロジーの進歩、標的治療に対する需要の増加、生物学的合成原薬の有効性に起因しています。生物学的合成によるカペシタビンの開発は、医薬品分野での関連性と採用にさらに貢献すると思われます。

地域別では、アジア太平洋のカペシタビン産業は、乳がんや大腸がんの罹患率の増加に牽引され、2023年～2032年にCAGR5.7％で拡大する見通しです。医療インフラの進歩、がん治療の選択肢に対する意識の高まり、高齢者人口の増加が、同地域におけるカペシタビンの消費をさらに促進すると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 カペシタビン市場洞察

  • エコシステム分析
  • COVID-19影響分析
  • 規制状況
    • 米国
    • 欧州
  • 価格分析：地域別
    • 販売価格
  • イノベーションと持続可能性
  • 業界への影響要因
    • 促進要因
    • 業界の潜在的リスクと課題
  • 成長可能性分析
  • ポーター分析
  • PESTEL分析

第4章 競合情勢

  • イントロダクション
  • 戦略展望マトリックス
  • 企業シェア分析
    • 世界
    • 北米
    • 欧州
    • アジア太平洋
  • 生産能力
  • 最終消費者上位20社のリストと連絡先／メールアドレス
  • 競合のポジショニングマトリックス

第5章 カペシタビンの市場推定・予測：症状別（2018年～2032年）

  • 主要動向：症状別
  • 乳がん
  • 大腸がん
  • 胃がん
  • 膵臓がん
  • その他の症状

第6章 カペシタビンの市場推定・予測：合成タイプ別（2018年～2032年）

  • 主要動向：合成タイプ別
  • 化学ベースAPI
  • 生物学的API
  • 高活性API（HPAPI）

第7章 カペシタビンの市場推定・予測：方法別（2018年～2032年）

  • 主要動向：方法別
  • 自社製造
  • 受託製造

第8章 カペシタビンの市場推計・予測：地域別（2018年～2032年）

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • マレーシア
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東・アフリカ

第9章 企業プロファイル

  • Sun Pharmaceutical Industries Ltd
  • Shilpa Medicare limited
  • Atom Pharma
  • Global Calcium
  • LGM Pharma
  • Dr. Reddy's Laboratories Ltd
  • Cipla Ltd
  • Zeon Pharma
  • Avanscure Lifesciences Pvt Ltd
  • Hepartex
図表

Data Tables

  • TABLE 1 Market revenue, by indication (2022)
  • TABLE 2 Market revenue, by synthesis type (2022)
  • TABLE 3 Market revenue, by mode (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global capecitabine market size, 2018 - 2024 (USD Million)
  • TABLE 6 Global capecitabine market size, 2025 - 2032 (USD Million)
  • TABLE 7 Global capecitabine market size, by region, 2018 - 2024 (USD Million)
  • TABLE 8 Global capecitabine market size, by region, 2025 - 2032 (USD Million)
  • TABLE 9 Global capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 10 Global capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 11 Global capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 12 Global capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 13 Global capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 14 Global capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 15 Capecitabine selling price per KG, by region 2022
  • TABLE 16 Industry impact forces
  • TABLE 17 Production capacity, 2022
  • TABLE 18 List of top 20 end consumers with contact details/email id
  • TABLE 19 Competitive positioning matrix: Classification criteria
  • TABLE 20 Breast cancer market size, 2018 - 2024 (USD Million)
  • TABLE 21 Breast cancer market size, 2025 - 2032 (USD Million)
  • TABLE 22 Colorectal cancer market size, 2018 - 2024 (USD Million)
  • TABLE 23 Colorectal cancer market size, 2025 - 2032 (USD Million)
  • TABLE 24 Gastric cancer market size, 2018 - 2024 (USD Million)
  • TABLE 25 Gastric cancer market size, 2025 - 2032 (USD Million)
  • TABLE 26 Pancreatic cancer market size, 2018 - 2024 (USD Million)
  • TABLE 27 Pancreatic cancer market size, 2025 - 2032 (USD Million)
  • TABLE 28 Other indications market size, 2018 - 2024 (USD Million)
  • TABLE 29 Other indications market size, 2025 - 2032 (USD Million)
  • TABLE 30 Chemical based API market size, 2018 - 2024 (USD Million)
  • TABLE 31 Chemical based API market size, 2025 - 2032 (USD Million)
  • TABLE 32 Biological API market size, 2018 - 2024 (USD Million)
  • TABLE 33 Biological API market size, 2025 - 2032 (USD Million)
  • TABLE 34 Highly potent API (HPAPI) market size, 2018 - 2024 (USD Million)
  • TABLE 35 Highly potent API (HPAPI) market size, 2025 - 2032 (USD Million)
  • TABLE 36 In-house manufacturing market size, 2018 - 2024 (USD Million)
  • TABLE 37 In-house manufacturing market size, 2025 - 2032 (USD Million)
  • TABLE 38 Contract manufacturing market size, 2018 - 2024 (USD Million)
  • TABLE 39 Contract manufacturing market size, 2025 - 2032 (USD Million)
  • TABLE 40 North America capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 41 North America capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 42 North America capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 43 North America capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 44 North America capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 45 North America capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 46 North America capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 47 North America capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 48 U.S. capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 49 U.S. capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 50 U.S. capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 51 U.S. capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 52 U.S. capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 53 U.S. capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 54 Canada capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 55 Canada capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 56 Canada capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 57 Canada capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 58 Canada capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 59 Canada capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 60 Europe capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 61 Europe capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 62 Europe capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 63 Europe capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 64 Europe capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 65 Europe capecitabine market size, by synthesis type, 2025-2032 (USD Million)
  • TABLE 66 Europe capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 67 Europe capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 68 Germany capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 69 Germany capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 70 Germany capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 71 Germany capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 72 Germany capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 73 Germany capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 74 UK capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 75 UK capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 76 UK capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 77 UK capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 78 UK capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 79 UK capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 80 France capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 81 France capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 82 France capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 83 France capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 84 France capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 85 France capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 86 Spain capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 87 Spain capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 88 Spain capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 89 Spain capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 90 Spain capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 91 Spain capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 92 Italy capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 93 Italy capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 94 Italy capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 95 Italy capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 96 Italy capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 97 Italy capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 98 Russia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 99 Russia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 100 Russia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 101 Russia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 102 Russia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 103 Russia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 104 Rest of Europe capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 105 Rest of Europe capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 106 Rest of Europe capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 107 Rest of Europe capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 108 Rest of Europe capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 109 Rest of Europe capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 110 Asia Pacific capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 111 Asia Pacific capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 112 Asia Pacific capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 113 Asia Pacific capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 114 Asia Pacific capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 115 Asia Pacific capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 116 Asia Pacific capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 117 Asia Pacific capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 118 Japan capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 119 Japan capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 120 Japan capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 121 Japan capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 122 Japan capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 123 Japan capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 124 China capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 125 China capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 126 China capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 127 China capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 128 China capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 129 China capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 130 India capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 131 India capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 132 India capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 133 India capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 134 India capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 135 India capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 136 Australia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 137 Australia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 138 Australia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 139 Australia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 140 Australia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 141 Australia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 142 South Korea capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 143 South Korea capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 144 South Korea capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 145 South Korea capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 146 South Korea capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 147 South Korea capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 148 Malaysia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 149 Malaysia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 150 Malaysia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 151 Malaysia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 152 Malaysia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 153 Malaysia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 154 Rest of Asia Pacific capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 155 Rest of Asia Pacific capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 156 Rest of Asia Pacific capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 157 Rest of Asia Pacific capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 158 Rest of Asia Pacific capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 159 Rest of Asia Pacific capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 160 Latin America capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 161 Latin America capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 162 Latin America capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 163 Latin America capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 164 Latin America capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 165 Latin America capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 166 Latin America capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 167 Latin America capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 168 Brazil capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 169 Brazil capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 170 Brazil capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 171 Brazil capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 172 Brazil capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 173 Brazil capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 174 Mexico capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 175 Mexico capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 176 Mexico capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 177 Mexico capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 178 Mexico capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 179 Mexico capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 180 Rest of Latin America capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 181 Rest of Latin America capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 182 Rest of Latin America capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 183 Rest of Latin America capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 184 Rest of Latin America capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 185 Rest of Latin America capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 186 Middle East & Africa capecitabine market size, by country, 2018 - 2024 (USD Million)
  • TABLE 187 Middle East & Africa capecitabine market size, by country, 2025 - 2032 (USD Million)
  • TABLE 188 Middle East & Africa capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 189 Middle East & Africa capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 190 Middle East & Africa capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 191 Middle East & Africa capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 192 Middle East & Africa capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 193 Middle East & Africa capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 194 Saudi Arabia capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 195 Saudi Arabia capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 196 Saudi Arabia capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 197 Saudi Arabia capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 198 Saudi Arabia capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 199 Saudi Arabia capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 200 South Africa capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 201 South Africa capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 202 South Africa capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 203 South Africa capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 204 South Africa capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 205 South Africa capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 206 UAE capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 207 UAE capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 208 UAE capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 209 UAE capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 210 UAE capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 211 UAE capecitabine market size, by mode, 2025 - 2032 (USD Million)
  • TABLE 212 Rest of Middle East & Africa capecitabine market size, by indication, 2018 - 2024 (USD Million)
  • TABLE 213 Rest of Middle East & Africa capecitabine market size, by indication, 2025 - 2032 (USD Million)
  • TABLE 214 Rest of Middle East & Africa capecitabine market size, by synthesis type, 2018 - 2024 (USD Million)
  • TABLE 215 Rest of Middle East & Africa capecitabine market size, by synthesis type, 2025 - 2032 (USD Million)
  • TABLE 216 Rest of Middle East & Africa capecitabine market size, by mode, 2018 - 2024 (USD Million)
  • TABLE 217 Rest of Middle East & Africa capecitabine market size, by mode, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Bottom-up approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Capecitabine industry 3600 synopses, 2018 - 2032
  • FIG 7 Capecitabine market ecosystem
  • FIG 8 Growth potential analysis, by indication
  • FIG 9 Growth potential analysis, by synthesis type
  • FIG 10 Growth potential analysis, by mode
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Strategic outlook matrix, 2022
  • FIG 14 Global company market share, 2022
  • FIG 15 North America company market share, 2022
  • FIG 16 Europe company market share, 2022
  • FIG 17 Asia Pacific company market share, 2022
  • FIG 18 Competitive positioning matrix, 2022
目次
Product Code: 6855

Capecitabine market size is projected to expand at 4.9% CAGR from 2023 to 2032. The rising incidence of various cancers, including breast and colorectal is fueling the demand for several effective chemotherapy drugs.

The rapid advancements in cancer treatment protocols is driving the adoption of capecitabine as an oral chemotherapy option. Additionally, the ongoing R&D activities along with the rising number of product approvals are leading to improved efficacy and safety of capecitabine. For instance, in December 2022, the U.S. FDA approved the updated labeling for capecitabine tablets as part of Project Renewal. This initiative, led by the Oncology Center of Excellence, aims to ensure clinically meaningful as well as scientifically up-to-date information for specific older oncology drugs.

The growing aging population across the globe coupled with the increasing cancer awareness is underscoring the significance of capecitabine in addressing the growing burden of cancer. The convenience of oral administration and reduced hospital visits for enhanced patient compliance are other factors driving the market growth.

The capecitabine industry is segregated into indication, synthesis type, mode, and region.

Based on indication, the industry value from the colorectal cancer segment is estimated to rise at 5.3% CAGR through 2032. The increasing prevalence of colorectal cancer and the surging advancements in cancer treatment protocols is driving the efficacy of capecitabine as a chemotherapy option. The effectiveness of capecitabine in treating colorectal cancer will, thus, add to the segment growth.

Capecitabine market share from the biological API synthesis type segment is projected to increase at 4.9% CAGR from 2023 to 2032. This growth is ascribed to the growing advancements in biotechnology, the increasing demand for targeted therapies, and the efficacy of biologically synthesized active pharmaceutical ingredients. The development of capecitabine through biological synthesis will further contribute to its relevance and adoption in the pharmaceutical sector.

Regionally, the Asia Pacific capecitabine industry is slated to expand at 5.7% CAGR from 2023 to 2032, driven by the increasing incidence of breast and colorectal cancers. The rising advancements in healthcare infrastructure, increasing awareness of cancer treatment options, and the growing aging population will further drive the consumption of capecitabine across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Capecitabine market 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Indication trends
    • 2.1.4 Synthesis type trends
    • 2.1.5 Mode trends

Chapter 3 Capecitabine Market Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 COVID-19 impact analysis
  • 3.3 Regulatory landscape
    • 3.3.1 U.S.
    • 3.3.2 Europe
  • 3.4 Pricing analysis, by region (USD Million)
    • 3.4.1 Selling price in USD per kg
  • 3.5 Innovation & sustainability
  • 3.6 Industry impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Increasing incidences of cancer
      • 3.6.1.2 Surging demand for generics
      • 3.6.1.3 Rising drug related research and development activities
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 High manufacturing cost
  • 3.7 Growth potential analysis
    • 3.7.1 By indication
    • 3.7.2 By synthesis type
    • 3.7.3 By mode
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Strategic outlook matrix, 2022
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Production capacity
  • 4.5 List of top 20 end consumers with contact details/email id
  • 4.6 Competitive positioning matrix, 2022

Chapter 5 Capecitabine Market Estimates and Forecast, By Indication, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by indication
  • 5.2 Breast cancer
  • 5.3 Colorectal cancer
  • 5.4 Gastric cancer
  • 5.5 Pancreatic cancer
  • 5.6 Other indications

Chapter 6 Capecitabine Market Estimates and Forecast, By Synthesis Type, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by synthesis type
  • 6.2 Chemical based API
  • 6.3 Biological API
  • 6.4 Highly potent API (HPAPI)

Chapter 7 Capecitabine Market Estimates and Forecast, By Mode, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by mode
  • 7.2 In-house manufacturing
  • 7.3 Contract manufacturing

Chapter 8 Capecitabine Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Malaysia
    • 8.4.7 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Sun Pharmaceutical Industries Ltd
  • 9.2 Shilpa Medicare limited
  • 9.3 Atom Pharma
  • 9.4 Global Calcium
  • 9.5 LGM Pharma
  • 9.6 Dr. Reddy's Laboratories Ltd
  • 9.7 Cipla Ltd
  • 9.8 Zeon Pharma
  • 9.9 Avanscure Lifesciences Pvt Ltd
  • 9.10 Hepartex